Investor List:

Top Pharmaceuticals Seed Investors (1262)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Vijay Pande, Managing Partner at Andreessen Horowitz
Vijay Pande
Andreessen Horowitz·Managing Partner
Sweet spot: $100K
Range: $100K - $10.0M
Investors in Menlo Park (CA)
Photo of Robert Garland, Venture Partner at New Enterprise Associates (NEA)
Robert Garland
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Photo of Bill Helman, Partner at Greylock
Bill Helman
Greylock·Partner
Sweet spot: $25.0M
Range: $500K - $200.0M
Investors in Boston (MA)
Photo of Jake Nunn, Venture Partner at SR One Capital Management
Jake Nunn
SR One Capital Management·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in Menlo Park (CA)
Photo of Alex Kopelyan, Partner at SOSV
Alex Kopelyan
SOSV·Partner
Sweet spot: $250K
Range: $250K - $250K
Investors in United States, Investors in San Francisco (CA), Investors in SF Bay Area (CA)
Photo of Parikshit Sharma, Principal at SOSV
Parikshit Sharma
SOSV·Principal
Sweet spot: $250K
Range: $250K - $500K
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Impact (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Material Science (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Food and Beverage (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Impact (Seed), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Medical Devices (Series A), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Food and Beverage (Series A), Investors in Impact (Series A), Investors in AgTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Impact (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Material Science (Series B), Investors in Material Science (Series B), Investors in Medical Devices (Series B), Investors in AgTech (Series B), Investors in Medical Devices (Series B), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in Food and Beverage (Series B), Investors in Impact (Series B), Investors in EnergyTech (Series B), Investors in EnergyTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Impact (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Shahram Seyedin-Noor, General Partner at Civilization Ventures
Shahram Seyedin-Noor
Civilization Ventures·General Partner
Sweet spot: $1M
Range: $50K - $10.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Cain McClary, Managing Partner at KdT Ventures
Cain McClary
KdT Ventures·Managing Partner
Sweet spot: $850K
Range: $700K - $1M
Investors in Austin (TX), Investors in United States, Investors in Asheville (NC), Investors in Boston (MA), Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in AI (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in EnergyTech (Seed), Investors in Analytics (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in AgTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Austin (Other Lists), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox
Firms investing in this space